N-Methylated pomalidomide
N-methylated pomalidomide (Pomalidomide-methyl), a derivative of Pomalidomide , is a cereblon (CRBN) ligand. N-methylated pomalidomide is unable to recruit CRBN that can be used as a negative control for Pomalidomide. N-methylated pomalidomide can be used to synthesize PROTAC[1].
Product Specifications
CAS Number
1352827-50-9
Product Name Alternative
Pomalidomide-methyl
UNSPSC
12352005
Hazard Statement
H302, H312, H332, H361
Target
Ligands for E3 Ligase
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
97.86
Smiles
O=C1C2=C(C(N1C3C(N(C)C(CC3)=O)=O)=O)C(N)=CC=C2
Molecular Formula
C14H13N3O4
Molecular Weight
287.27
Precautions
H302, H312, H332, H361
References & Citations
[1]Yokoo H, et al. Development of a Hematopoietic Prostaglandin D Synthase-Degradation Inducer. ACS Med Chem Lett. 2021 Jan 14;12 (2) :236-241.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cereblon
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Accuris™ Precision Balance, 3200 grams, readability 0.01grams, 115V
CD3e (T-Cell Marker) (rC3e/1308), CF568 conjugate, 0.1mg/mL
